Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4
Article in Clinical Nutrition (June 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Clinical Nutrition (June 2024)
Article in Molecular Medicine (March 2024)
Article in Lipids in Health and Disease (February 2024)